Izindaba NemicimbiI-Peptide Products Division e-JYMed idlulise ngokungenaphutha ukuhlolwa kwendawo okuvela ku-FDA.

Sihalalisela ngokufudumele uphiko lwethu lwemikhiqizo ye-Polypeptide ngokuphasisa ngempumelelo i-US FDA yokuhlola indawo "engenasici"!

Ukwedlula ukuhlolwa kwe-FDA endaweni "engenasici" kuwumcimbi omkhulu emlandweni wethu wokuthuthukiswa kwe-cGMP.Akusho nje kuphela ukuthi i-API yethu ithole iphasiphothi yokungena emakethe yase-US, kodwa futhi ifakazela ukuthi ukuqaliswa kwe-cGMP enkampanini yethu kuye kwahambisana kancane kancane namazinga omhlaba.